Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: patient outcomes and impact of bendamustine dosing

Suzanne O Arulogun^*, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, RayMun Koo, Aideen T O'Neill, Josephine M I Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J Kersten, Monique C Minnema, Eirini Koutoumanou, Dima El-Sharkawi, Kim LintonDipti Talaulikar, Helen McCarthy, Mark Bishton, George Follows, Ashutosh Wechalekar, Shirley P D'Sa

^*Corresponding author for this work

Department of Hematology
Cancer
Infection & Immunity
Regenerative Medicine and Stem Cells

Research output: Contribution to journal › Article › Academic › peer-review

Sort by
Weight
Alphabetically

Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: patient outcomes and impact of bendamustine dosing

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology